AMBEV S.A. Capital Increase Due to Stock Option Exercise

The Board of Directors of AMBEV S.A. has approved a capital increase resulting from the exercise of stock options granted under the company's Stock Option Plan. This plan was initially approved by shareholders on July 30, 2013, and the specific program for 2026 was approved on January 28, 2026. The capital increase amounts to BRL 33,127,274.55, bringing the new total capital stock to BRL 58,308,213,544.96. This involves the issuance of 2,026,133 new common shares at an issuance price of BRL 16.35 per share. The potential dilution resulting from this issuance is approximately 0.012855% in relation to the number of shares and 0.056846% in relation to the capital stock. The approval and homologation of this capital increase by the Board of Directors occurred on March 30, 2025.